These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 28465764)
1. Sociodemographic Determinants of Out-of-Pocket Expenditures for Patients Using Prescription Drugs for Rheumatoid Arthritis. Mukherjee K; Kamal KM Am Health Drug Benefits; 2017 Feb; 10(1):7-15. PubMed ID: 28465764 [TBL] [Abstract][Full Text] [Related]
2. Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends. Atzinger CB; Guo JJ Am Health Drug Benefits; 2017 Feb; 10(1):27-36. PubMed ID: 28465766 [TBL] [Abstract][Full Text] [Related]
3. The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States. Ding Q; Shiltz D; Hossami D; Konieczny AM Expert Rev Pharmacoecon Outcomes Res; 2022 Dec; 22(8):1231-1241. PubMed ID: 36004551 [TBL] [Abstract][Full Text] [Related]
4. Health services utilization, out-of-pocket expenditure, and underinsurance among insured non-elderly cancer survivors in the United States, 2011-2015. Karim MA; Singal AG; Ohsfeldt RL; Morrisey MA; Kum HC Cancer Med; 2021 Aug; 10(16):5513-5523. PubMed ID: 34327859 [TBL] [Abstract][Full Text] [Related]
5. Ophthalmic Medication Expenditures and Out-of-Pocket Spending: An Analysis of United States Prescriptions from 2007 through 2016. Chen EM; Kombo N; Teng CC; Mruthyunjaya P; Nwanyanwu K; Parikh R Ophthalmology; 2020 Oct; 127(10):1292-1302. PubMed ID: 32359935 [TBL] [Abstract][Full Text] [Related]
6. Impact of Out-of-Pocket Costs on Prescription Fills Among New Initiators of Biologic Therapies for Rheumatoid Arthritis. Hopson S; Saverno K; Liu LZ; AL-Sabbagh A; Orazem J; Costantino ME; Pasquale MK J Manag Care Spec Pharm; 2016 Feb; 22(2):122-30. PubMed ID: 27015251 [TBL] [Abstract][Full Text] [Related]
7. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs. Daniel GW; Malone DC J Manag Care Pharm; 2007 Mar; 13(2):142-54. PubMed ID: 17330975 [TBL] [Abstract][Full Text] [Related]
8. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008. Cheng LI; Rascati KL Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663 [TBL] [Abstract][Full Text] [Related]
9. Out-of-Pocket Spending for Ambulatory Physical Therapy Services From 2008 to 2012: National Panel Survey. Chevan J; Riddle DL; Reed SD Phys Ther; 2015 Dec; 95(12):1680-91. PubMed ID: 26112257 [TBL] [Abstract][Full Text] [Related]
10. Disparities in care by insurance status for individuals with rheumatoid arthritis: analysis of the medical expenditure panel survey, 2006-2009. Cifaldi M; Renaud J; Ganguli A; Halpern MT Curr Med Res Opin; 2016 Dec; 32(12):2029-2037. PubMed ID: 27551731 [TBL] [Abstract][Full Text] [Related]
11. Per-Prescription Drug Expenditure by Source of Payment and Income Level in the United States, 1997 to 2015. Tang W; Xie J; Kong F; Malone DC Value Health; 2019 Aug; 22(8):871-877. PubMed ID: 31426927 [TBL] [Abstract][Full Text] [Related]
12. [Out-of-pocket medical spending for care in patients with recent onset rheumatoid arthritis]. Westhoff G; Listing J; Zink A Z Rheumatol; 2004 Oct; 63(5):414-24. PubMed ID: 15517302 [TBL] [Abstract][Full Text] [Related]
13. Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes in Patients With Rheumatoid Arthritis. Vu M; Carvalho N; Clarke PM; Buchbinder R; Tran-Duy A J Rheumatol; 2021 Aug; 48(8):1221-1229. PubMed ID: 33323533 [TBL] [Abstract][Full Text] [Related]
14. Living arrangements, chronic diseases, and prescription drug expenditures among Korean elderly: vulnerability to potential medication underuse. Park EJ; Sohn HS; Lee EK; Kwon JW BMC Public Health; 2014 Dec; 14():1284. PubMed ID: 25516064 [TBL] [Abstract][Full Text] [Related]
15. Sex differences in healthcare expenditures among adults with diabetes: evidence from the medical expenditure panel survey, 2002-2011. Williams JS; Bishu K; Dismuke CE; Egede LE BMC Health Serv Res; 2017 Apr; 17(1):259. PubMed ID: 28399859 [TBL] [Abstract][Full Text] [Related]
16. Compliance with biologic therapies for rheumatoid arthritis: do patient out-of-pocket payments matter? Curkendall S; Patel V; Gleeson M; Campbell RS; Zagari M; Dubois R Arthritis Rheum; 2008 Oct; 59(10):1519-26. PubMed ID: 18821651 [TBL] [Abstract][Full Text] [Related]
17. Reducing out-of-pocket expenditures to reduce poverty: a disaggregated analysis at rural-urban and state level in India. Garg CC; Karan AK Health Policy Plan; 2009 Mar; 24(2):116-28. PubMed ID: 19095685 [TBL] [Abstract][Full Text] [Related]
18. Healthcare expenditures among community-dwelling adults with thyroid cancer in the United States: A propensity score matched analysis. Bhattacharjee S; Khobrani M; Alrabiah Z; Bilal J; Riaz IB Heliyon; 2019 Jun; 5(6):e01995. PubMed ID: 31297464 [TBL] [Abstract][Full Text] [Related]
19. Trends in Out-of-Pocket Burden in United States Adults with Kidney Disease: 2002-2011. Ozieh MN; Bishu KG; Dismuke CE; Egede LE Am J Med Sci; 2019 Aug; 358(2):149-158. PubMed ID: 31331452 [TBL] [Abstract][Full Text] [Related]
20. Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey. Kawatkar AA; Jacobsen SJ; Levy GD; Medhekar SS; Venkatasubramaniam KV; Herrinton LJ Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1649-56. PubMed ID: 22674912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]